For loss‐of‐function assay, transwell migration assay was applied using CRC cells transfected with CLK3 siRNA, showing that CLK3 knockdown could inhibit CRC cell migration (Figure S9). This evidence concerns the gene CLK3 and colorectal carcinoma.